Phase II evaluation of orally administered idarubicin in patients with advanced breast cancer

Cancer Treat Rep. 1987 Dec;71(12):1289-90.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Breast Neoplasms / drug therapy*
  • Carcinoma / drug therapy*
  • Daunorubicin / administration & dosage
  • Daunorubicin / adverse effects
  • Daunorubicin / analogs & derivatives*
  • Drug Evaluation
  • Female
  • Humans
  • Idarubicin
  • Middle Aged

Substances

  • Idarubicin
  • Daunorubicin